Literature DB >> 1891766

Inhibitory effects of activated protein C and heparin on thrombotic arterial occlusion in rat mesenteric arteries.

H Araki1, K Nishi, N Ishihara, K Okajima.   

Abstract

Effects of human activated protein C (APC) and heparin on thrombus formation were examined using small mesenteric arteries of rats and video-recording system attached to a microscope. To induce thrombosis we damaged the vessel wall over a short segment by compression and exposed the damaged media to the blood stream. Platelet-rich thrombus enlarged gradually at the damaged site, occluded the vascular lumen for a short period and then flowed away. Such thrombus formation was observed several times after a compression damage. An intravenous administration of APC significantly decreased the total occlusion time from 6.4 +/- 0.7 min at control to 2.2 +/- 0.4 min at 0.9 mg/kg given over 1 min (mean +/- SEM, n = 6, p less than 0.01), and from 6.5 +/- 1.0 min to 1.0 +/- 0.3 min at 3.0 mg/kg (n = 6, p less than 0.01). An intravenous heparin (300 and 1000 U/kg) also decreased the total occlusion time significantly from 6.2 +/- 0.8 to 2.2 +/- 0.8 min (n = 6, p less than 0.05) and from 5.4 +/- 0.8 to 0.8 +/- 0.7 min (n = 6, p less than 0.01), respectively. APC prolonged APTT from 11 +/- 1 sec (n = 5) at control to 50 +/- 5 sec (n = 5) at 0.9 mg/kg and to 87 +/- 8 sec (n = 5) at 3.0 mg/kg, while heparin prolonged APTT to more than 120 sec in all 5 rats at both doses. APTT prolongation by APC was significantly attenuated by inhibiting its residual activity in the plasma samples using monoclonal antibody.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1891766     DOI: 10.1016/0049-3848(91)90194-2

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  8 in total

1.  No Prognostic Importance of Resistance to Activated Protein C in Unstable Coronary Artery Disease Despite Signs of Thrombin Activation.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998       Impact factor: 2.300

Review 2.  Novel antithrombotic drugs in development.

Authors:  M Verstraete; P Zoldhelyi
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

3.  Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.

Authors:  S R Hanson; J H Griffin; L A Harker; A B Kelly; C T Esmon; A Gruber
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

Review 4.  Genetic susceptibility to inflammatory injury and various adverse outcomes.

Authors:  John M Murkin; Keith R Walley
Journal:  J Extra Corpor Technol       Date:  2009-03

5.  Protein S as an in vivo cofactor to activated protein C in prevention of microarterial thrombosis in rabbits.

Authors:  B Arnljots; B Dahlbäck
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

6.  Intravascular hemolysis triggers ADP-mediated generation of platelet-rich thrombi in precapillary pulmonary arterioles.

Authors:  Tomasz Brzoska; Ravi Vats; Margaret F Bennewitz; Egemen Tutuncuoglu; Simon C Watkins; Margaret V Ragni; Matthew D Neal; Mark T Gladwin; Prithu Sundd
Journal:  JCI Insight       Date:  2020-07-23

7.  Tissue factor, blood coagulation, and beyond: an overview.

Authors:  Arthur J Chu
Journal:  Int J Inflam       Date:  2011-09-20

8.  Human activated protein C variants in a rat model of arterial thrombosis.

Authors:  Karl Malm; Björn Arnljots; Björn Dahlbäck
Journal:  Thromb J       Date:  2008-10-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.